BridgeMD
New treatment option for Anxiety Disorders
Official title Transdiagnostic Internet-delivered Intervention for Adolescents With Anxiety and Depression
ClinicalTrials.gov ID: NCT06724666
What this study is testing
- What it's testing
- The goal of this clinical trial is to test the efficacy of a transdiagnostic Internet-delivered interventions for Romanian adolescents with anxiety and/ or depression. The main questions it aims to answer are: What is the clinical efficacy of the Internet-delivered intervention?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 13 to 17
You may be able to join if
- elevated symptoms of anxiety or depression/ internalizing problems (T score\> 60) at intake (based on Youth self-report completed by adolescents)
- primary diagnosis of an anxiety/depressive disorder based on DSM-5 criteria according to ADIS-5-C/P interview
- age 13-17
- able to read and understand Romanian language
- Currently unmedicated or on stable and adequate doses of medication for at least 6 weeks before treatment onset
You likely can't join if
- severe mental disorder (psychosis, severe depression, bipolar disorder, based on clinical interview)
- any condition that interferes with the protocol implementation (e.g., physical illness or sensory impairment that interferes with behavioral tasks...
- active suicidal ideation (assessed by child psychiatrist during clinical interview) in the last month
- currently following CBT/ psychotherapy for anxiety/depression, in the last 6 months
- fMRI incompatible (based on safety questionnaire)
- Being diagnosed with an intellectual disability, pervasive developmental disorder, an alcohol and/or substance dependence disorder, reading...
See the full eligibility criteria
- elevated symptoms of anxiety or depression/ internalizing problems (T score\> 60) at intake (based on Youth self-report completed by adolescents)
- primary diagnosis of an anxiety/depressive disorder based on DSM-5 criteria according to ADIS-5-C/P interview
- age 13-17
- able to read and understand Romanian language
- Currently unmedicated or on stable and adequate doses of medication for at least 6 weeks before treatment onset
- Internet access
- severe mental disorder (psychosis, severe depression, bipolar disorder, based on clinical interview)
- any condition that interferes with the protocol implementation (e.g., physical illness or sensory impairment that interferes with behavioral tasks such as exposure, behavioral activation, unavailable for the next 3...
- active suicidal ideation (assessed by child psychiatrist during clinical interview) in the last month
- currently following CBT/ psychotherapy for anxiety/depression, in the last 6 months
- fMRI incompatible (based on safety questionnaire)
- Being diagnosed with an intellectual disability, pervasive developmental disorder, an alcohol and/or substance dependence disorder, reading disabilities (based on clinical interview).
- Current treatment with benzodiazepines
The study team makes the final eligibility decision.
Where it's taking place
- Cluj-Napoca, Romania
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 13 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cluj-Napoca, Romania. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.